Active Ingredient(s):Paliperidone Palmitate FDA Approved: * May 18, 2015 Pharm Company: *JANSSEN PHARMS Category:Antipsychotic
Paliperidone, sold under the trade name Invega among others, is an atypical antipsychotic. It is mainly used to treat schizophrenia and schizoaffective disorder.
It is marketed by Janssen Pharmaceuticals. An extended release formulation is available that uses the OROS extended release system to allow for once-daily dosing. Paliperidone palmitate is a long-acting injectable formulation of paliperidone palmitoyl ester.
It is on the World Health Organization's List of Essential Medicines....
* May have multiple approval dates, manufacturers, or labelers.